Protara Therapeutics, Inc. Common Stock
TARA •
Sell Open
Signal type
Sell
Status
Open
Open Price
$5.21
Stop Loss
$5.78
Performance
1.54%
Days Open
34
Signal Setup
Signal Type Sell
Status Open
Open Date Mar 12, 2026
Open Price $5.21
Stop Loss $5.78
Timespan Day
Company Profile
Name Protara Therapeutics, Inc. Common Stock
Ticker TARA
Market Cap $116.90M
Sector BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Latest Close $5.13
List Date Jan 10, 2020
Description
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
Website Open Company Website